Quantification of human diamine oxidase

Objectives: Diamine oxidase (DAD) is essential for extracellular degradation of histamine. For decades activity assays with inherent limitations were used to quantify the relative amounts of DAO. No reference DAD standard is available. Absolute DAO amounts cannot be determined. Controversy exists, whether DAD is circulating or not in non-pregnant individuals. The role of DAO as biomarker in various diseases is ambiguous. It is not clear, whether precise quantification of human DAO antigen using commercially available enzyme-linked immunosorbent assays (ELISAs) is possible. The objective was to develop a precise and robust ELISA to quantify DAO in various biological fluids. Design and methods: A research prototype ELISA was established using a mouse monoclonal antibody for capturing and a polyclonal rabbit serum IgG fraction for the detection of human DAO. The limit of blank (LoB), limit of detection (LoD) and estimated limit of quantification (eLoQ) and normal DAO concentrations in serum and plasma were determined. Results: The LoB, LoD and eLoQ derived from 42 standard curves are 0.27, 0.48 and 0.7 ng/mL respectively. The detection range using the LoD as the lower and the highest DAO standard as the upper boundary is 0.5 to 450 ng/mL. Serum and plasma mean/median concentrations are between 0.5 and 1.5 ng/mL in healthy volunteers (n = 58) and mastocytosis patients (n = 19) and plateau at approximately 145 ng/mL (n = 16) during pregnancy. Accurate quantification was not influenced by heparin (DAD is a heparin-binding protein), lipaemic or hemolytic serum. The measured DAO antigen concentrations are in close agreement with published enzymatic activity data using radioactive putrescine as substrate. Conclusions: This research prototype ELISA is able to reliably and accurately quantify human DAO in different biological fluids. The potential of DAO as biomarker in various diseases can be evaluated. (C) 2017 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.